drugset / Trial / NCT04811118
The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere
RandomizedCrossoverSingle-blindTreatment
Summary
This is a randomized, open-label, two-period, crossover trial to evaluate the pharmacokinetic profiles of albumin-bound docetaxel for intravenous infusion and Taxotere in patients with advanced solid tumors.
Timeline
- Start
- 2021-05-18
- Primary completion
- 2022-10-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |